跳至主要内容
临床试验/NCT03201497
NCT03201497Unknown不适用

Prospective Registration of Severe Pneumocystis Jiroveci Pneumonia Requiring ICU

Peking Union Medical College Hospital0 个研究点目标入组 300 人开始时间: 2017年7月1日最近更新:
适应症

试验速览

阶段
不适用
入组人数
300
主要终点
28-day ICU mortality

研究概览

简要总结

the investigators aim to set up a multicenter registry study for severe PJP requiring ICU admission. The purpose of this study is

  1. to establish a prospective severe PJP registry about clinical characteristics, laboratory and radiographic findings, critical care management and outcomes.
  2. to explore the predictive factors associated with outcomes ;
  3. to compare the difference between PJP patients with HIV and without HIV infection.

详细描述

Pneumocystis jiroveci pneumonia (PJP) is a common opportunistic infection in immunocompromised patients. Although the mortality of patients with mild to moderate PJP has declined substantially, the reported outcomes of severe PJP requiring ICU admission, especially with mechanical ventilation are grave. The data on this group of patients is very limited and mainly comes from retrospective studies.

the investigators aim to set up a multicenter registry study for patient with severe PJP requiring ICU admission to provide comprehensive descriptive data on diagnosis, clinical course, critical care management and outcomes in a large cohort.

All patients with PJP admitted to the participating ICU during a two-year period will be enrolled. The CRF will be made available to the participating sites as a printable paper-based CRF.

The following individual patient data for study participants will be collected:

  • General demographic information
  • Presence of risk factors for PJP and comorbid condition
  • use of prophylactic SMZ/TMP, immunosuppressive medications prior to ICU admission
  • Information about PJP and co-infection diagnosis
  • vital signs, laboratory(blood serum and BALF sample) and radiologic data at ICU admission and during ICU stay
  • organ failures and severity of the disease at admission, new onset of organ failures during ICU stay
  • Medications for PJP, time course and modalities and settings for respiratory support
  • ICU, 28-day mortality, hospital, 90-day mortality

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • diagnosis with PJP, confirmed by PCR or methenamine silver stain of sample from BALF, aspirate or sputum;
  • ICU admission due to PJP-related respiratory failure

排除标准

  • 未提供

结局指标

主要结局

28-day ICU mortality

时间窗: Day 28

28 days mortality after ICU admission

次要结局

  • ICU length of stay(Day 90)
  • occurrence of pneumothorax or pneumomediastinum(day 28)
  • mechanical ventilation free days(day 28)
  • hospital mortality(Day 90 (censored at hospital discharge if discharge prior to Day 90))
  • hospital length of stay(Day 90)
  • occurrence of SMZ/TMP treatment failure(day 7 after SMZ/TMP treatment)
  • occurrence of non-invasive mechanical ventilation(day 28)
  • ICU acquired infectious disease(day 28)

研究者

申办方类型
Other
责任方
Sponsor

相似试验